Depression Study

Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD) can be a long-term illness, with many patients experiencing relapse. Clinical Trials of Texas, Inc. is currently enrolling patients to evaluate the relapse prevention effects of an FDA-approved study medication on patients with MDD.

Qualified Participants Must:

  • Be 18 to 75 years of age
  • Be experiencing symptoms of depression
  • Experience recurrent depressive episodes
  • Additional criteria may apply

Qualified Participants Receive:

  • Study medication, testing and care from a board-certified physician at no cost
  • Compensation may be available for board and travel

Check out some of our other studies.